Paper41244802
Identification and validation of novel risk genes for intervertebral disc disorder by integrating large-scale multi-omics analyses and experimental studies.
Zhang Z and 6 others. Front Med (Lausanne), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Identification and validation of novel risk genes for intervertebral disc disorder by integrating large-scale multi-omics analyses and experimental studies. Papers, record 41244802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41244802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification and validation of novel risk genes for intervertebral disc disorder by integrating large-scale multi-omics analyses and experimental studies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35421606 | Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity. | Ageing Res Rev | 2022 | https://conductscience.org/library/papers/35421606 | PubMed |
| 2 | 38528617 | Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/38528617 | PubMed |
| 3 | 36416764 | Transcriptome-wide association study and eQTL colocalization identify potentially causal genes responsible for human bone mineral density GWAS associations. | Elife | 2022 | https://conductscience.org/library/papers/36416764 | PubMed |
| 4 | 32913098 | The GTEx Consortium atlas of genetic regulatory effects across human tissues. | Science | 2020 | https://conductscience.org/library/papers/32913098 | PubMed |
| 5 | 33118080 | Down-Regulation of microRNA-30d Alleviates Intervertebral Disc Degeneration Through the Promotion of FOXO3 and Suppression of CXCL10. | Calcif Tissue Int | 2021 | https://conductscience.org/library/papers/33118080 | PubMed |
| 6 | 29022597 | Genetic effects on gene expression across human tissues. | Nature | 2017 | https://conductscience.org/library/papers/29022597 | PubMed |
| 7 | 37658226 | Transcriptome-wide association studies: recent advances in methods, applications and available databases. | Commun Biol | 2023 | https://conductscience.org/library/papers/37658226 | PubMed |
| 8 | 28003146 | Injectable hyaluronic acid down-regulates interferon signaling molecules, IGFBP3 and IFIT3 in the bovine intervertebral disc. | Acta Biomater | 2017 | https://conductscience.org/library/papers/28003146 | PubMed |
| 9 | 38942297 | The association of lumbar intervertebral disc degeneration with low back pain is modified by underlying genetic propensity to pain. | Spine J | 2025 | https://conductscience.org/library/papers/38942297 | PubMed |
| 10 | 21273369 | Characterization of mouse sperm TMEM190, a small transmembrane protein with the trefoil domain: evidence for co-localization with IZUMO1 and complex formation with other sperm proteins. | Reproduction | 2011 | https://conductscience.org/library/papers/21273369 | PubMed |
| 11 | 38816384 | Lumbar instability remodels cartilage endplate to induce intervertebral disc degeneration by recruiting osteoclasts via Hippo-CCL3 signaling. | Bone Res | 2024 | https://conductscience.org/library/papers/38816384 | PubMed |
| 12 | 40595969 | Integrating brain proteomes and genetics to identify novel risk genes in chronic widespread musculoskeletal pain. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595969 | PubMed |
| 13 | 38670440 | CILP2 promotes hypertrophic scar through Snail acetylation by interaction with ACLY. | Biochim Biophys Acta Mol Basis Dis | 2024 | https://conductscience.org/library/papers/38670440 | PubMed |
| 14 | 26463451 | Fibrotic-like changes in degenerate human intervertebral discs revealed by quantitative proteomic analysis. | Osteoarthritis Cartilage | 2016 | https://conductscience.org/library/papers/26463451 | PubMed |
| 15 | 23325358 | FOXOs: signalling integrators for homeostasis maintenance. | Nat Rev Mol Cell Biol | 2013 | https://conductscience.org/library/papers/23325358 | PubMed |
| 16 | 28356508 | The druggable genome and support for target identification and validation in drug development. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/28356508 | PubMed |
| 17 | 33510477 | Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis. | Nat Genet | 2021 | https://conductscience.org/library/papers/33510477 | PubMed |
| 18 | 39625652 | YTHDF2-dependent m6A modification of FOXO3 mRNA mediates TIMP1 expression and contributes to intervertebral disc degeneration following ROS stimulation. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39625652 | PubMed |
| 19 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 20 | 39385717 | Inhibition of CILP2 Improves Glucose Metabolism and Mitochondrial Dysfunction in Sarcopenia via the Wnt Signalling Pathway. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39385717 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42744959 | The degenerating intervertebral disc leading to structural failure of the aging spine: from cellular pathways, risk factors, radiological diagnosis, to surgical management. | Geroscience | 2026 | https://conductscience.org/library/papers/42744959 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41244802
GET https://conductscience.org/api/papers/v1/41244802/references?page=2